HRCT of nodular disease

Johan Coolen (Leuven, Belgium)

Source: International Congress 2017 – PG8 High-resolution computed tomography for pulmonologists: basics and beyond
Session: PG8 High-resolution computed tomography for pulmonologists: basics and beyond
Session type: Postgraduate Course
Number: 89

WebcastSlide presentation

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Johan Coolen (Leuven, Belgium). HRCT of nodular disease. International Congress 2017 – PG8 High-resolution computed tomography for pulmonologists: basics and beyond

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Depiction of malignancy in patients with diffuse interstitial lung disease (DILD) presenting with nodular opacities
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


HRCT of cystic lung diseases
Source: International Congress 2017 – PG8 High-resolution computed tomography for pulmonologists: basics and beyond
Year: 2017


HRCT imaging vs chest-x-ray assessment of endothoracal sarcoidosis extent
Source: Eur Respir J 2006; 28: Suppl. 50, 676s
Year: 2006

Ultrasonographic features of typical HRCT signs of interstitial lung diseases
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

HRCT in the diagnosis of diffuse lung disease - overlap issues
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010


High-resolution CT (HRCT) reflects disease progression in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017

CT and interstitial lung disease
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018


CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease
Source: International Congress 2018 – CC6 Interstitial lung diseases
Year: 2018


Pulmonary necrobiotic nodules: a rare extraintestinal manifestation of Crohn's disease
Source: Eur Respir Rev 2009; 18: 47-50
Year: 2009


The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 489s
Year: 2004

The contribution of thorax computed tomography to differantial diagnosis in cavitating pulmonary diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 246s
Year: 2003

Two patients with a nodular lung pattern
Source: Annual Congress 2007 - Radiology Grand Round: an interactive session
Year: 2007

Histological findings of the computed tomography halo in pulmonary sarcoidosis
Source: Eur Respir J 2009; 34: 281-283
Year: 2009


Radiological features of NTM pulmonary disease in patients with bronchiectasis
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Computed tomographic biomarkers in idiopathic pulmonary fibrosis
Source: International Congress 2019 – PG5 Novel insights into the diagnostic algorithm for interstitial lung diseases
Year: 2019


HRCT of drug-induced lung diseases
Source: International Congress 2017 – PG8 High-resolution computed tomography for pulmonologists: basics and beyond
Year: 2017


Chest CT findings in IgG4-related diseases
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010

Differential diagnosis of ground-glass opacity lung nodules
Source: International Congress 2018 – Multidisciplinary approach to ground-glass opacities
Year: 2018


Utility of FDG-PET in the diagnosis of pulmonary nodules
Source: Eur Respir J 2003; 22: Suppl. 45, 245s
Year: 2003

Pulmonary cryptococcosis in immunocompetent patients: HRCT and pathologic
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006